跳至主要内容
临床试验/JPRN-UMIN000018147
JPRN-UMIN000018147已完成2 期

Evaluation of tramadol / acetaminophen combination tablets to evaluate the effectiveness of analgesic treatment in cancer patients who had the symptomatic chemotherapy induced peripheral neuropathy. - Tramcet for CIP

Department of Internal Medicine, Medical Oncology, School of Medicine, Kyorin University0 个研究点目标入组 25 人开始时间: 2015年7月2日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)In taking acetaminophen or tramadol component. 2)Opioids is cotraindicated. 3)Acetaminophen is contraindicated. 4)The patient that antidepressant, an antiepileptic drug, antiarrhythmic, pregabalin, Goshajinkigan were started within four weeks from registration. 5)Peripheral neuropathy induced by diabetes, alcohol and drugs except platinum agents and taxane. 6)Taking selegiline hydrochloride.

研究者

发起方
Department of Internal Medicine, Medical Oncology, School of Medicine, Kyorin University

相似试验

Evaluation of tramadol / acetaminophen combination... | 临床试验